Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks the expression of human epidermal growth factor receptor 2 (HER2), progesterone receptor (PR), and estrogen receptor (ER). This evidence concerns the gene ERBB2 and breast carcinoma.